Brinzolamide

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Image:Brinzolamide.svg
Brinzolamide
Systematic (IUPAC) name
(5R)-5-ethylamino-3-(3-methoxypropyl)-
2,2-dioxo-2λ6,9-dithia-
3-azabicyclo[4.3.0]nona-7,10-diene-
8-sulfonamide
Identifiers
CAS number 138890-62-7
ATC code S01EC04
PubChem 68844
DrugBank APRD00475
Chemical data
Formula C12H21N3O5S3 
Mol. mass 383.51 g/mol
Pharmacokinetic data
Bioavailability  ?
Protein binding ~60%
Metabolism  ?
Half life 111 days
Excretion  ?
Therapeutic considerations
Licence data

EUUS

Pregnancy cat.

C(US)

Legal status

-only(US)

Routes Ophthalmic

Brinzolamide is a carbonic anhydrase inhibitor.

References

  • Ermis S, Ozturk F, Inan U (2005). "Comparing the effects of travoprost and brinzolamide on intraocular pressure after phacoemulsification.". Eye 19 (3): 303-7. PMID 15258611.
  • Iester M, Altieri M, Michelson G, Vittone P, Traverso C, Calabria G. "Retinal peripapillary blood flow before and after topical brinzolamide.". Ophthalmologica 218 (6): 390-6. PMID 15564757.
  • Kaup M, Plange N, Niegel M, Remky A, Arend O (2004). "Effects of brinzolamide on ocular haemodynamics in healthy volunteers.". Br J Ophthalmol 88 (2): 257-62. PMID 14736787.
Personal tools